Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Juhaina M. Abu Ershaid"'
Publikováno v:
Pharmacia, Vol 71, Iss , Pp 1-10 (2024)
Background: This study aims to present the development and evaluation of freeze-dried erythromycin nanocrystals to enhance the solubility, dissolution rate, and antibacterial potency of erythromycin. Results: Erythromycin nanocrystals had a particle
Externí odkaz:
https://doaj.org/article/fe380aea94fc4911875e0742e3ca3698
Autor:
Juhaina M. Abu Ershaid, Han Zhang, May Tayyem, Akmal H. Sabri, Ryan F. Donnelly, Lalitkumar K. Vora
Publikováno v:
Journal of Functional Biomaterials, Vol 15, Iss 11, p 316 (2024)
Background: Skin and soft tissue infections (SSTIs) present significant treatment challenges. These infections often require systemic antibiotics such as vancomycin, which poses a risk for increased bacterial resistance. Topical treatments are hinder
Externí odkaz:
https://doaj.org/article/e9eb1e9014db4e7ead6e89a2b9496495
Autor:
Yaocun Li, Chunyang Zhang, Xianbing Dai, Juhaina M. Abu-Ershaid, Mingshan Li, Li Zhao, Yara A. Naser, Marco T.A. Abbate, Ryan F. Donnelly
Publikováno v:
Advanced Healthcare Materials. 10:2100996
Traditional drug delivery routes possess various disadvantages which make them unsuitable for certain population groups, or indeed unsuitable for drugs with certain physicochemical properties. As a result, a variety of alternative drug delivery route
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fe49e946f168c12b8f4e9f6ed63f1e1
https://doi.org/10.1002/adhm.202100996
https://doi.org/10.1002/adhm.202100996
Autor:
Chunyang Zhang, Li Zhao, Marco T.A. Abbate, Fabiana Volpe-Zanutto, Yara A. Naser, Xianbing Dai, Ryan F. Donnelly, Mingshan Li, Juhaina M. Abu-Ershaid, Alejandro Javier Paredes, Inken K. Ramöller, Peter E. McKenna
Publikováno v:
Paredes, A J, McKenna, P E, Ramöller, I K, Naser, Y A, Volpe-Zanutto, F, Li, M, Abbate, M T A, Zhao, L, Zhang, C, Abu-Ershaid, J M, Dai, X & Donnelly, R F 2021, ' Microarray Patches: Poking a Hole in the Challenges Faced When Delivering Poorly Soluble Drugs ', Advanced Functional Materials, vol. 31, no. 1, 2005792 . https://doi.org/10.1002/adfm.202005792
Poorly soluble drugs constitute more than 60% of currently marketed pharmaceuticals with over two‐thirds of promising new chemical entities failing to enter a clinical setting due to solubility issues. Although oral formulations have made some impa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::606a573c3c3324848af25939d98e63f0
https://doi.org/10.1002/adfm.202005792
https://doi.org/10.1002/adfm.202005792